Verteporfin might reduce retinitis pigmentosa neurodegeneration possibly due to the interplay of microglia and Müller cells

Vol 1, 2023 - 169172
Trabalho
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Retinitis pigmentosa (RP) is one of the major causes of blindness, affecting more than 41 million people worldwide. Although RP has several associated mutations and different etiologies, it eventually leads to a massive rod and cone cell loss. In the first stage of the disease, gene mutations lead to rod cell death. In the autosomal recessive variation, the mutation is due to single-nucleotide polymorphism in Pde6B gene. Genetic therapies have been extensively used in the last years trying to prevent rod cell death, but the gene-editing method is not an effective treatment so far due to secondary cone cell death. The loss of cone cells implicates the YAP/TEAD Hippo pathway, which in turn seems to be a consequence of the Pde6B mutation and neuroinflammation environment. Verteporfin (VP) has been used in the clinical treatment of retinoblastoma, and it is a potential molecule to prevent cone cell death once it acts on YAP phosphorylation and prevents the YAP/TEAD conjugation.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Eixo Temático
  • 10 - Neurobiologia